Pharmacy Medical Policy Updates
The following Pharmacy Medical Policy programs have been updated today, June 1, 2021:
Effective July 1, 2021:
- GLP-1
- Androgens and Anabolic Steroids
- Insulin
- Methotrexate Injectable
- Multiple Sclerosis
- Opioid ER
- Opioid IR Duration Limit
- Self-Administered Oncology
- VMAT2 Inhibitors
- CGRP
- HCPA CGRP
- Biologic Immunomodulators
- Lupus (Previously Benlysta)
- Sucraid
- Xhance
- Zeposia
- Zokinvy
Many of our pharmacy medical policies are maintained through our pharmacy benefit manager, Prime Therapeutics.
To find pharmacy medical policies specific to a medication list, please select a medication list at the bottom of our prior authorization page of our website, https://www.bcbsks.com/providers/precertification-prior-authorization.
If you have any questions regarding this newsletter, please contact your BCBSKS provider representative/consultant.
Institutional Providers
Professional Providers